title: Mother-to-child transmission of human immunodeficiency virus type 1 and type 2 and dual infection: a cohort study in Banfora, Burkina Faso.
abstract: A prospective cohort study on the mother-to-child transmission of human immunodeficiency virus type 1 (HIV1), type 2 (HIV2) and dual positivity (HIV1 + HIV2) was carried out in Banfora, West Burkina Faso. The study samples consist of 117 newborns of HIV-seropositive women matched to 234 newborns of HIV-seronegative women. Among cases, 91 were born of HIV1-seropositive mothers, 15 were born of HIV2-seropositive mothers and 11 were born of HIV1 and HIV2 dual-seropositive mothers and were included in an 18-month follow-up. Calculation of the mother-to-child transmission rate was according to the recommendations of the European Economic Community working group. The HIV1 mother-to-child transmission rate was estimated to be 27.8% (95% confidence interval (CI) 24.5 to 32.4) with one method and 25.5% (95% CI 13.5 to 37.5) with a second method. For HIV2, this rate was estimated to be 29.5% (95% CI 26.0 to 39.8) and was not statistically different from the HIV1 mother-to-child transmission rate. No case of transmission was observed in children born of dual seropositive mothers. Survival rate at month 18 was significantly lower for children born of HIV1 mothers: 83.7% (95% CI 78.2 to 92.2). Survival rates were similar between children born of HIV2-seropositive (86.7), dual HIV1 + 2-positive (100) and seronegative mothers (92.0%). Findings suggest a higher mother-to-child transmission rate of HIV2 in children born in Burkina Faso than in Europe and a low clinical expression of HIV2 in children.
authors.affiliation: Groupe d'Etudes Epidemiologiques et Prophylactiques (GEEP), Centre Hospitalier, France.
authors.forename: T
authors.initials: T
authors.lastname: Prazuck
authors.forename: J M
authors.initials: JM
authors.lastname: Yameogo
authors.forename: B
authors.initials: B
authors.lastname: Heylinck
authors.forename: L T
authors.initials: LT
authors.lastname: Ouedraogo
authors.forename: A
authors.initials: A
authors.lastname: Rochereau
authors.forename: J B
authors.initials: JB
authors.lastname: Guiard-Schmid
authors.forename: P
authors.initials: P
authors.lastname: Lechuga
authors.forename: P
authors.initials: P
authors.lastname: Agranat
authors.forename: M
authors.initials: M
authors.lastname: Cot
authors.forename: J E
authors.initials: JE
authors.lastname: Malkin
mesh_terms: D015492:AIDS Serodiagnosis; D000328:Adult; D000349:Africa; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000401:mortality / Q000635:transmission*; D015528:HIV Seroprevalence; D015497:HIV-1 / Q000302:isolation & purification*; D015498:HIV-2 / Q000302:isolation & purification*; D006801:Humans; D015994:Incidence; D007223:Infant; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology*; D011446:Prospective Studies; D015996:Survival Rate